Status
Conditions
Treatments
About
Comparative study to assess the ability of the patient specific PEEK sheets in ridge augmentation with using mixed Autogenous/Xenogenic bone graft vs the Bone Shell Technique regarding the time, accuracy and donor site morbidity .
Full description
A- Intervention Group (Patient specific PEEK sheets)
Preoperative Computed tomography will be done to the patients. Using special software, 3D models will be obtained and used to design the custom made PEEK sheets. The final STL (Standard Tessellation Language) files will be sent to the lab to be milled/printed. Autogenous bone graft will be taken from Chin/Retromolar graft and will be mixed with xenogenic bone graft in 1:1 ratio. After bone exposure, the ridge will be decorticated and the prefabricated PEEK sheets will be fixed with titanium screws and the space between the sheets and the ridge will be filled with the prepared bone graft. Wounds closure will be done. CT scan will be done postoperative. After 6 months another CT scan will be done for evaluation and comparison. Then the titanium screws will be removed and implants will be placed.
B- Control Group (Autogenous bone shell technique)
Preoperative Computed tomography will be done to the patients Bone graft will be harvested from the chin/retromolar region and a cortico- cancellous bone block will be obtained then divided into two pieces used as the shells. The bone shells will be trimmed and adjusted to the recipient site and the remaining bone will be milled and mixed with Xenogenic bone graft with ratio 1:1 The bone shells will be anchored in the host bone with titanium screws and the space between the shells and the alveolar bone will be filled by the bone graft mix. Wounds closure will be done. CT scan will be done. After 6 months another CT scan will be done for evaluation and comparison. Then the patient will go for micro screws removal along with implant placement.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
14 participants in 2 patient groups
Loading...
Central trial contact
Mohamed M Shaker, PhD; Ola A El-Morsy, B.D.S
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal